13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q1 2022. See the latest, Q2 2026 →
Reported value
$801.12B
−3.5% on the quarter before
Positions
4,975
163 new · 164 sold out
Top 10
24.5%
of the value
Est. gain
−$45.75B
on stocks held all quarter
Est. return
−5.6%
on those stocks since Q4 2021
Positions as of Mar 31, 2022, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2021. Striped tiles are options.
Largest buys
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$1.35BAdded · 5.6% → 5.9%+7,729,767 shares
- Microsoft~$1.33BAdded · 5.2% → 5.1%+4,317,583 shares
- S&P Global Inc~$897.8MAdded · 0.3% → 0.3%+2,194,128 shares
- AMD~$844.7MAdded · 0.3% → 0.4%+7,746,048 shares
- Tesla~$823.4MAdded · 1.7% → 1.9%+766,147 shares
- Amazon~$707.4MAdded · 2.9% → 3.0%+217,581 shares
- Alphabet~$487.2MAdded · 1.9% → 1.9%+175,582 shares
- Nvidia~$408.9MAdded · 1.5% → 1.5%+1,502,408 shares
- Medtronic Plc~$340.3MAdded · 0.3% → 0.4%+3,073,909 shares
- Constellation Energy~$310.9MNew · 0.0% → 0.0%+5,541,478 shares
Largest sells
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Xilinx Inc~$1.08BSold out · 0.1% → 0.0%−5,101,641 shares
- Ihs Markit Ltd~$972.2MSold out · 0.1% → 0.0%−7,332,993 shares
- Merck & Co. Inc.~$306.6MCut · 0.4% → 0.5%−3,745,670 shares
- Nuance Communications Inc~$204.6MSold out · 0.0% → 0.0%−3,704,229 shares
- Federal Rlty Invt Tr~$201.2MSold out · 0.0% → 0.0%−1,477,819 shares
- Apollo Global Mgmt Inc~$193.3MSold out · 0.0% → 0.0%−2,672,033 shares
- Cyrusone Inc~$181.9MSold out · 0.0% → 0.0%−2,027,856 shares
- Athene Holding Ltd~$124.3MSold out · 0.0% → 0.0%−1,494,715 shares
- Intuitive Surgical~$112.4MCut · 0.3% → 0.2%−373,743 shares
- Arena Pharmaceuticals Inc~$101.2MSold out · 0.0% → 0.0%−1,088,735 shares
Holdings
As of Mar 31, 2022. Changes are in shares against Dec 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +2.9% · price −1.6% | 5.9% | $47.39B | −$771.9M | ||||||||
| MicrosoftCOM · shares +3.3% · price −8.3% | 5.1% | $41.04B | −$3.60B | ||||||||
| AmazonCOM · shares +3.0% · price −2.2% | 3.0% | $24.09B | −$531.5M | ||||||||
| TeslaCOM · shares +5.6% · price +2.0% | 1.9% | $15.41B | +$282.3M | ||||||||
| AlphabetCAP STK CL A · shares +3.3% · price −4.0% | 1.9% | $15.25B | −$613.5M | ||||||||
| AlphabetCAP STK CL C · shares +2.2% · price −3.5% | 1.7% | $13.29B | −$468.1M | ||||||||
| NvidiaCOM · shares +3.6% · price −7.2% | 1.5% | $11.81B | −$886.6M | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +1.3% · price +18.0% | 1.3% | $10.70B | +$1.61B | ||||||||
| MetaCL A · shares +2.0% · price −33.9% | 1.1% | $9.19B | −$4.62B | ||||||||
| Unitedhealth Group IncCOM · shares +1.8% · price +1.6% | 1.0% | $8.08B | +$123.2M | ||||||||
| Johnson & JohnsonCOM · shares +1.4% · price +3.6% | 0.99% | $7.96B | +$273.3M | ||||||||
| Procter & Gamble Co/TheCOM · shares +1.4% · price −6.6% | 0.84% | $6.71B | −$467.6M | ||||||||
| Visa Inc.COM CL A · shares +2.0% · price +2.4% | 0.84% | $6.70B | +$150.8M | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.4% · price −13.9% | 0.82% | $6.59B | −$1.05B | ||||||||
| Exxon Mobil CorpCOM · shares +0.8% · price +35.0% | 0.73% | $5.88B | +$1.51B | ||||||||
| MastercardCL A · shares +1.8% · price −0.5% | 0.69% | $5.50B | −$28.7M | ||||||||
| Pfizer IncCOM · shares +3.8% · price −12.3% | 0.68% | $5.42B | −$732.1M | ||||||||
| Chevron CorpCOM · shares +2.6% · price +38.8% | 0.67% | $5.38B | +$1.46B | ||||||||
| Home Depot IncCOM · shares +2.4% · price −27.9% | 0.65% | $5.17B | −$1.95B | ||||||||
| Bank Of America CorpCOM · shares +0.2% · price −7.3% | 0.60% | $4.84B | −$382.2M | ||||||||
| Abbvie IncCOM · shares +0.7% · price +19.8% | 0.58% | $4.64B | +$760.6M | ||||||||
| Costco Wholesale CorpCOM · shares +4.7% · price +1.5% | 0.55% | $4.43B | +$61.3M | ||||||||
| BroadcomCOM · shares +3.3% · price −5.4% | 0.55% | $4.42B | −$241.8M | ||||||||
| Eli LillyCOM · shares +3.9% · price +3.7% | 0.55% | $4.37B | +$149.5M | ||||||||
| Coca-Cola Co/TheCOM · shares +1.4% · price +4.7% | 0.54% | $4.36B | +$193.2M | ||||||||
| Total · 4,975 positions | 100% | $801.12B | −$45.75B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2021 to Q1 2022: 4,809 stocks held throughout, down $45.75B (−5.6%).
- Berkshire Hathaway Inc-Cl B+$1.61B+18%
- Exxon Mobil Corp+$1.51B+35%
- Chevron Corp+$1.46B+39%
- Abbvie Inc+$760.6M+20%
- Conocophillips+$626.5M+39%
- PayPal−$1.40B−39%
- Netflix−$1.63B−38%
- Home Depot Inc−$1.95B−28%
- Microsoft−$3.60B−8%
- Meta−$4.62B−34%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 14 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |